Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 70
13
Diseases
68
Unique genes
0.216
Avg. similarity score
Brain tumor-polyposis syndrome
Most-connected disease (8 links)
Disease
Searched: Gastrointestinal hemorrhage
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Gastrointestinal hemorrhage
Brain tumor-polyposis syndrome
Familial adenomatous polyposis
gastric adenocarcinoma and proximal polyposis of the stomach
Gastrointestinal neoplasms
Cenani-lenz syndrome
Desmoid tumor
Intestinal polyps
Macrocytic anemia
Medulloblastoma
Hyperemesis gravidarum
immunodeficiency 97 with autoinflammation
intellectual developmental disorder, autosomal dominant 65
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Brain tumor-polyposis syndrome | 8 | 8 | 1 |
| Familial adenomatous polyposis | 8 | 8 | 1 |
| gastric adenocarcinoma and proximal polyposis of the stomach | 8 | 8 | 1 |
| Gastrointestinal neoplasms | 7 | 7 | 4 |
| Cenani-lenz syndrome | 4 | 4 | 2 |
| Desmoid tumor | 4 | 4 | 3 |
| Gastrointestinal hemorrhage | 3 | 3 | 6 |
| Intestinal polyps | 3 | 3 | 6 |
| Macrocytic anemia | 3 | 3 | 4 |
| Medulloblastoma | 3 | 3 | 49 |
| Hyperemesis gravidarum | 1 | 1 | 4 |
| immunodeficiency 97 with autoinflammation | 1 | 1 | 1 |
| intellectual developmental disorder, autosomal dominant 65 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| APC | 10 / 13 | Brain tumor-polyposis syndrome, Cenani-lenz syndrome, Desmoid tumor, Familial adenomatous polyposis and 6 more |
| CTNNB1 | 2 / 13 | Desmoid tumor, Medulloblastoma |
| ERBB2 | 2 / 13 | Gastrointestinal neoplasms, Medulloblastoma |
| GDF15 | 2 / 13 | Gastrointestinal neoplasms, Hyperemesis gravidarum |
| HIC1 | 2 / 13 | Gastrointestinal neoplasms, Medulloblastoma |
| KDM4B | 2 / 13 | intellectual developmental disorder, autosomal dominant 65, Medulloblastoma |
| PIK3CG | 2 / 13 | immunodeficiency 97 with autoinflammation, Medulloblastoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Pathways in cancer | KEGG | 20 / 533 | 6.6× | 6.94e-12 | 1.21e-9 ✓ sig. |
| Breast cancer | KEGG | 9 / 148 | 10.7× | 1.36e-7 | 8.30e-6 ✓ sig. |
| MicroRNAs in cancer | KEGG | 12 / 311 | 6.8× | 1.46e-7 | 8.81e-6 ✓ sig. |
| Hedgehog signaling pathway | KEGG | 6 / 56 | 18.9× | 6.84e-7 | 3.35e-5 ✓ sig. |
| Basal cell carcinoma | KEGG | 6 / 63 | 16.8× | 1.39e-6 | 6.24e-5 ✓ sig. |
| Kaposi sarcoma-associated herpesvirus infection | KEGG | 9 / 196 | 8.1× | 1.47e-6 | 6.52e-5 ✓ sig. |
| Proteoglycans in cancer | KEGG | 9 / 204 | 7.8× | 2.04e-6 | 8.58e-5 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 7 / 108 | 11.4× | 2.41e-6 | 9.97e-5 ✓ sig. |
| RUNX3 regulates WNT signaling | Reactome | 3 / 8 | 66.2× | 9.53e-6 | 3.11e-4 ✓ sig. |
| Small cell lung cancer | KEGG | 6 / 93 | 11.4× | 1.36e-5 | 4.23e-4 ✓ sig. |
| Epstein-Barr virus infection | KEGG | 8 / 204 | 6.9× | 1.86e-5 | 5.51e-4 ✓ sig. |
| Endometrial cancer | KEGG | 5 / 59 | 15.0× | 1.98e-5 | 5.79e-4 ✓ sig. |
| Gastric cancer | KEGG | 7 / 150 | 8.2× | 2.11e-5 | 6.12e-4 ✓ sig. |
| Human cytomegalovirus infection | KEGG | 8 / 226 | 6.3× | 3.89e-5 | 1.01e-3 ✓ sig. |
| Non-small cell lung cancer | KEGG | 5 / 73 | 12.1× | 5.59e-5 | 1.35e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| regulation of cell population proliferation | GO:0042127 | 12 / 201 | 16.4× | 7.41e-12 | 2.80e-9 ✓ sig. |
| cell population proliferation | GO:0008283 | 13 / 263 | 13.6× | 9.96e-12 | 3.67e-9 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 14 / 524 | 7.3× | 4.80e-9 | 8.85e-7 ✓ sig. |
| negative regulation of DNA-templated transcription | GO:0045892 | 15 / 631 | 6.5× | 6.06e-9 | 1.09e-6 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 13 / 504 | 7.1× | 2.77e-8 | 4.05e-6 ✓ sig. |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 5 / 26 | 52.8× | 3.41e-8 | 4.81e-6 ✓ sig. |
| positive regulation of miRNA transcription | GO:1902895 | 6 / 56 | 29.4× | 5.22e-8 | 6.93e-6 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 15 / 778 | 5.3× | 9.68e-8 | 1.16e-5 ✓ sig. |
| regulation of DNA-templated transcription | GO:0006355 | 20 / 1,454 | 3.8× | 1.27e-7 | 1.47e-5 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 18 / 1,208 | 4.1× | 1.97e-7 | 2.13e-5 ✓ sig. |
| regulation of gene expression | GO:0010468 | 11 / 402 | 7.5× | 2.03e-7 | 2.19e-5 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 16 / 1,002 | 4.4× | 4.37e-7 | 4.16e-5 ✓ sig. |
| chromatin organization | GO:0006325 | 11 / 449 | 6.7× | 6.09e-7 | 5.50e-5 ✓ sig. |
| positive regulation of fibroblast proliferation | GO:0048146 | 5 / 55 | 25.0× | 1.66e-6 | 1.25e-4 ✓ sig. |
| Wnt signaling pathway | GO:0016055 | 8 / 232 | 9.5× | 1.95e-6 | 1.42e-4 ✓ sig. |